Partners

Collaborators

Our Partners

Vaccitech has established partnerships with leading institutions across the globe to support the development of its programs. Hover over the logos below for more information.

Vaccitech has entered into non-exclusive licensure of its T cell induction platform in oncology, and is committed to advancing the use of its platform for oncology in combination with checkpoint inhibitors.

To contact us about partnering, please email info@vaccitech.co.uk

CANSINO BIOLOGICS INC. (CanSinoBIO) is a dynamic, leading Chinese bio-tech blazing new paths in R&D, manufacturing and commercialisation of vaccine products for human use.
Website

Cancer Research UK is the world’s leading cancer charity dedicated to saving lives through research. The charity’s pioneering work into the prevention, diagnosis and treatment of cancer has helped save millions of lives.
Website

The University of Oxford is a collegiate research university located in Oxford, England, United Kingdom. While having no known date of foundation, there is evidence of teaching as far back as 1096, making it the oldest university in the English-speaking world and the world’s second-oldest surviving university.
Website

Enara Bio is pioneering the use of Dark Antigens™ to deliver targeted off-the-shelf cancer vaccines and other immunotherapies for treating and preventing cancer.
Website

Ludwig Cancer Research is an international community of distinguished scientists dedicated to preventing and controlling cancer. Established in 1971 by Daniel K. Ludwig, the institute continues to pioneer immunological research in oncology.
Website
OXGENE™ accelerates the discovery and production of cell and gene therapies, addressing key industry bottlenecks and facilitating new therapeutic approaches. We redefine ‘possible’ in mammalian cell engineering.
Website
Oxford University Innovation is a wholly-owned subsidiary of the University of Oxford. OUI manages the University’s technology transfer and consulting activities and provide an innovation management service to clients around the world.
Website
CANSINO BIOLOGICS INC. (CanSinoBIO) is a dynamic, leading Chinese bio-tech blazing new paths in R&D, manufacturing and commercialisation of vaccine products for human use.

Website

Cancer Research UK is the world’s leading cancer charity dedicated to saving lives through research. The charity’s pioneering work into the prevention, diagnosis and treatment of cancer has helped save millions of lives.

Website

The University of Oxford is a collegiate research university located in Oxford, England, United Kingdom. While having no known date of foundation, there is evidence of teaching as far back as 1096, making it the oldest university in the English-speaking world and the world’s second-oldest surviving university.

Website

Enara Bio is pioneering the use of Dark Antigens™ to deliver targeted off-the-shelf cancer vaccines and other immunotherapies for treating and preventing cancer.

Website

Ludwig Cancer Research is an international community of distinguished scientists dedicated to preventing and controlling cancer. American businessman Daniel K. Ludwig began to support cancer research with the establishment of the Ludwig Institute for Cancer Research in 1971. Today, the scientific efforts endowed through his resources have grown to encompass the Ludwig Institute and the Ludwig Centers and professorships at six U.S. institutions.

Website

OXGENE™ accelerates the discovery and production of cell and gene therapies, addressing key industry bottlenecks and facilitating new therapeutic approaches. We redefine ‘possible’ in mammalian cell engineering.

Website

Oxford University Innovation is a wholly-owned subsidiary of the University of Oxford. OUI manages the University’s technology transfer and consulting activities and provide an innovation management service to clients around the world.

Website